Skip to main content

Table 2 Visual and refractive outcomes in 108 eyes that underwent phakic refractive lens implantation for myopia correction

From: Real-world study of phakic refractive lens for correction of high myopia

Parameter (mean ± SD)

Pre-op

1 day

1 week

1 month

3 months

6 months

12 months

P#

UDVA (logMAR)

1.35 ± 0.36 (n = 100)

0.32 ± 0.30 (n = 105)

0.22 ± 0.18 (n = 106)

0.18 ± 0.19 (n = 87)

0.19 ± 0.21 (n = 87)

0.18 ± 0.19 (n = 76)

0.18 ± 0.21 (n = 73)

 < 0.001

Efficacy index

–

0.72

0.84

0.91

0.92

0.92

0.94

–

CDVA (logMAR)

0.15 ± 0.21 (n = 108)

0.13 ± 0.19 (n = 75)

0.04 ± 0.13 (n = 97)

0.02 ± 0.11 (n = 77)

0.01 ± 0.14 (n = 76)

0.03 ± 0.13 (n = 68)

0.02 ± 0.13 (n = 54)

 < 0.001

Safety index

–

1.04

1.22

1.25

1.30

1.24

1.28

–

MRSE (D)

 − 14.49 ± 4.22 (n = 108)

 − 1.22 ± 1.26 (n = 75)

 − 1.13 ± 0.97 (n = 101)

 − 0.96 ± 1.08 (n = 79)

 − .09 ± 0.99 (n = 72)

 − 1.14 ± 0.93 (n = 69)

 − 1.14 ± 0.97 (n = 54)

 < 0.001

  1. Pre-op = preoperative; UDVA = uncorrected distance visual acuity; CDVA = corrected distance visual acuity; MRSE = manifest refraction spherical equivalent; D = diopter
  2. # Preoperative to postoperative, linear mixed model